European Neuroendocrine Tumor Society

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.2967/jnumed.119.237990 Efficacy of Peptide Receptor Radionuclide Therapy for Esthesioneuroblastoma
https://doi.org/10.1089/ars.2013.5706 Redox-Sensitive Structure and Function of the First Extracellular Loop of the Cell–Cell Contact Protein Claudin-1: Lessons from Molecular Structure to Animals
https://doi.org/10.1016/j.bpg.2013.01.001 Biotherapies for GEP-NETs
https://doi.org/10.1007/s00280-018-3734-1 Octreotide SC depot in patients with acromegaly and functioning neuroendocrine tumors: a phase 2, multicenter study
https://doi.org/10.2967/jnumed.118.223537 Novel Structured Reporting Systems for Theranostic Radiotracers
https://doi.org/10.1136/jitc-2021-003487 Time 2EVOLVE: predicting efficacy of engineered T-cells – how far is the bench from the bedside?
https://doi.org/10.1136/jitc-2022-005930 Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG
https://doi.org/10.1097/rlu.0000000000003937 The Combined Interpretation of 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT in Metastatic Gastroenteropancreatic Neuroendocrine Tumors
https://doi.org/10.1111/jne.13100 ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology
https://doi.org/10.1007/978-3-642-27994-2_25 Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors in Germany: First Results of a Multi-institutional Cancer Registry
https://doi.org/10.1136/jitc-2020-000742 Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
https://doi.org/10.1111/jne.13060 Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)
https://doi.org/10.1158/1078-0432.ccr-21-3058 Expanding Therapeutic Opportunities for Extrapulmonary Neuroendocrine Carcinoma
https://doi.org/10.1111/ddg.14706_g S2k‐Leitlinie – Kutane Lymphome (ICD10 C82–C86): Update 2021
https://doi.org/10.1007/s00259-022-05848-z Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study
https://doi.org/10.1007/s00101-011-1872-5 Extrakorporale Membranoxygenierung und schweres Schädel-Hirn-Trauma
https://doi.org/10.1111/ddg.13372_g S2k‐Leitlinie – Kutane Lymphome Update 2016 – Teil 1: Klassifikation und Diagnostik (ICD10 C82 ‐ C86)
https://doi.org/10.1111/jne.13105 ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors
https://doi.org/10.1111/codi.14033 Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme
https://doi.org/10.1007/s00104-013-2591-z Eingriffsspezifische Komplikationen der Hernienchirurgie
https://doi.org/10.1159/000463386 The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro
https://doi.org/10.1055/a-1008-9827 Empfehlungen zur Früherkennung, Risikoreduktion, Überwachung und Therapie bei Patienten mit Lynch-Syndrom
https://doi.org/10.3390/diagnostics11020334 Cost-Effectiveness Analysis of 68Ga DOTA-TATE PET/CT, 111In-Pentetreotide SPECT/CT and CT for Diagnostic Workup of Neuroendocrine Tumors
https://doi.org/10.1007/s11864-022-00969-x Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms
https://doi.org/10.3389/fmed.2023.1169970 Long-term prognostic factors for PRRT in neuroendocrine tumors
https://doi.org/10.1136/heartjnl-2020-316612 Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation
https://doi.org/10.1111/cen.13758 Characterization of cyclic Cushing's disease using late night salivary cortisol testing
https://doi.org/10.1111/jne.13359 Use and perceived utility of [ 18 F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022
https://doi.org/10.1007/s12020-021-02859-y Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
https://doi.org/10.1111/codi.15978 Nodal metastases in small rectal neuroendocrine tumours
https://doi.org/10.1016/j.dld.2023.06.021 Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma
https://doi.org/10.1016/j.thorsurg.2014.05.006 Medical Treatment of Advanced Thoracic Neuroendocrine Tumors
https://doi.org/10.1007/s00259-023-06245-w Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors
https://doi.org/10.1111/jne.13184 Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): Prevalence, clinicopathological characteristics and survival outcome in a cohort of 311 patients with well‐differentiated lung neuroendocrine tumours
https://doi.org/10.1055/s-0043-103275 Epidemiologie der Parkinsonerkrankung und aktuelle ambulante Versorgungskonzepte in Deutschland
https://doi.org/10.1007/978-3-662-54375-7 Die geburtshilfliche Anästhesie
https://doi.org/10.1097/mnm.0b013e328362cca6 Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours
Pancreatic neuroendocrine neoplasms.
https://doi.org/10.1097/js9.0000000000001080 A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study
https://doi.org/10.1097/rlu.0000000000005006 Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies
https://doi.org/10.1186/s40644-023-00556-9 Diagnostic performance of PET/CT in the detection of liver metastases in well-differentiated NETs
https://doi.org/10.1530/erc-23-0032 Glucagon cell hyperplasia and neoplasia: a recently recognized endocrine receptor disease
https://doi.org/10.1016/j.diii.2023.06.007 Neuroendocrine liver metastases treated using transarterial radioembolization: Identification of prognostic parameters at 68Ga-DOTATATE PET/CT
https://doi.org/10.1007/s00059-011-3488-6 Qualitätsverbesserung von Koronardiagnostik und -intervention durch „Virtual-Reality“-Simulation
https://doi.org/10.1182/blood.v128.22.222.222 Health-Related Quality of Life (HRQoL) of Blinatumomab Versus Standard of Care (SOC) Chemotherapy in Patients with Relaspsed or Refractory Philadelphia Negative B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label Phase 3 Study (TOWER)
https://doi.org/10.1111/jne.13138 Real‐world efficacy of lutetium peptide receptor radionuclide therapy in patients with neuroendocrine tumours
https://doi.org/10.3389/fonc.2023.992316 Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [18F]SiTATE
https://doi.org/10.1186/s12957-023-03072-z Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study
https://doi.org/10.1111/jne.13018 Increase of Ki‐67 index and influence on mortality in patients with neuroendocrine neoplasms
https://doi.org/10.1111/jne.13205 Association of lymph node metastases, grade and extent of mesenteric lymph node dissection in locoregional small intestinal neuroendocrine tumors with recurrence‐free survival
https://doi.org/10.1038/s41598-024-58664-w The 3D in vitro Adrenoid cell model recapitulates the complexity of the adrenal gland
https://doi.org/10.1210/clinem/dgae241 Opposing Effects of Cannabidiol in Patient-derived Neuroendocrine Tumor, Pheochromocytoma/Paraganglioma Primary Cultures
https://doi.org/10.1097/cad.0000000000001508 BRAF V600E-mutated large cell neuroendocrine carcinoma responding to targeted therapy: a case report and review of the literature
https://doi.org/10.1097/rlu.0000000000004629 Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4–Directed Molecular Imaging and Therapy
https://doi.org/10.1002/pbc.31420 Pediatric Neuroendocrine Tumors in Denmark: Incidence, Management, and Outcome From 1995 to 2020
https://doi.org/10.14309/ajg.0000000000003409 International, Multicenter Analysis of Endoscopic Full-Thickness Resection of Duodenal Neuroendocrine Tumors
https://doi.org/10.1159/000336049 ABC1 Consensus Conference – a German Perspective
https://doi.org/10.1177/17474930221095698 Elevation of cardiac biomarkers in stroke is associated with pathological findings on cardiac MRI—results of the HEart and BRain interfaces in Acute Stroke study
https://doi.org/10.1073/pnas.2405001121 Enhancer landscape of lung neuroendocrine tumors reveals regulatory and developmental signatures with potential theranostic implications
https://doi.org/10.1055/a-1101-3244 Die Rolle der gemeinschaftlichen Selbsthilfe bei der Bewältigung einer Krebserkrankung
https://doi.org/10.3390/diagnostics12123096 Quantitative Airway Assessment of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) on CT as a Novel Biomarker
https://doi.org/10.1007/s00259-025-07073-w One-day dual-tracer examination in neuroendocrine neoplasms: a real advantage of low activity LAFOV PET imaging
https://doi.org/10.1007/s00104-021-01512-8 Endokrine und neuroendokrine Tumoren
https://doi.org/10.1007/s11307-024-01899-w Volumetric Parameters Derived from CXCR4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas
https://doi.org/10.1210/clinem/dgaf077 Brief, Low-impact, High-intensity Osteogenic Loading in Postmenopausal Osteoporosis: A Quasi-experimental Case-series Study
https://doi.org/10.1530/erc-23-0041 Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model
https://doi.org/10.1007/978-3-031-47425-5_15 Multimodal Context-Aware Detection of Glioma Biomarkers Using MRI and WSI
https://doi.org/10.1186/s40658-025-00720-z Low-activity [18F]-somatostatin receptor (SSTR) imaging using [18F]SiTATE on a long axial field-of-view PET/CT scanner
https://doi.org/10.1093/ejendo/lvaf052 Identification of hypertension subtypes using microRNA profiles and machine learning
https://doi.org/10.1161/strokeaha.124.050052 Thrombectomy With Low ASPECTS: The Roles of Infarct Volume and Postacute Neurological Status
https://doi.org/10.1111/jne.70062 Controversies in NEN: An ENETS position statement on nutritional support in neuroendocrine neoplasms
https://doi.org/10.1159/000541101 Longitudinal Changes in Ki-67 Indices in Small-Intestinal Neuroendocrine Tumours and Their Impact on Survival
https://doi.org/10.1093/ejendo/lvae163 Impact of sex hormones on pheochromocytomas, paragangliomas, and gastroenteropancreatic neuroendocrine tumors
https://doi.org/10.1097/md.0000000000041853 Clinical characteristics and treatment patterns of patients with gastroenteropancreatic neuroendocrine neoplasia in Germany receiving peptide receptor radionuclide therapy: A real-world data registry-based study
https://doi.org/10.1186/s12935-025-03776-0 Carbonyl reductase 4 suppresses colorectal cancer progression through the DNMT3B/CBR4/FASN/mTOR axis
https://doi.org/10.1210/clinem/dgaf263 Serum 5-Hydroxyindoleacetic Acid Measurements for the Diagnosis and Follow-up of Carcinoid Syndrome
https://doi.org/10.1530/erc-25-0073 Anti-tumor potential of combinatory GSK3 inhibition in human 3D models of pancreatic neuroendocrine tumors and patient-derived GEP-NET primary cultures
https://doi.org/10.1016/j.pan.2022.04.014 Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysis
https://doi.org/10.1097/mpa.0000000000002034 Feasibility and Satisfaction of Using NET VITALS Self-assessment Tool Among Patients With Neuroendocrine Tumors
https://doi.org/10.2967/jnumed.124.268288 [18F]FDG and [68Ga]Ga-FAPI-04–Directed Imaging for Outcome Prediction in Patients with High-Grade Neuroendocrine Neoplasms
https://doi.org/10.1210/clinem/dgae901 Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma
https://doi.org/10.1007/s00259-025-07301-3 First-in-human administration of [61Cu]Cu-NODAGA-LM3 and head-to-head comparison with [68Ga]Ga-DOTA-TOC PET/CT as part of the phase I/II COPPER PET in NET study
https://doi.org/10.1159/000546613 Prognosis of NETs has there been improvement over the last 30 years
https://doi.org/10.1080/14796694.2025.2514402 Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinoma
https://doi.org/10.1016/j.dld.2025.09.011 The indolent nature of type 1 gastric neuroendocrine tumors under 1 cm
https://doi.org/10.1007/s11377-020-00428-9 Neuroendokrine Neoplasien des Gastrointestinaltrakts
https://doi.org/10.1007/s00108-023-01635-6 Präzisionsmedizin in der Endokrinologie am Beispiel des medullären Schilddrüsenkarzinoms
https://doi.org/10.2967/jnumed.125.269619 Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer
https://doi.org/10.7150/thno.112588 Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy
https://doi.org/10.1007/s00223-025-01414-5 Consensus-Based Recommendations for the Diagnosis, Treatment, and Monitoring of Hypoparathyroidism: Insights from the DACH Region
https://doi.org/10.1530/eo-24-0083 Diagnostic characteristics, treatment outcomes, and prognostic factors in glucagonomas
https://doi.org/10.1021/acs.jcim.5c00972 Virtual Compound Screening for Discovery of Dopamine D1 Receptor Biased Allosteric Modulators
https://doi.org/10.3389/fendo.2025.1687570 Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine Tumors
https://doi.org/10.1530/eo-25-0041 Paltusotine versus octreotide: different effects on radioligand uptake in neuroendocrine tumours
https://doi.org/10.2967/jnumed.125.270755 Diagnostic Performance of [ 18 F]PSMA-1007 PET/CT on Proven PSMA-Positive Hepatocellular Carcinoma: A Prospective Clinical Study
https://doi.org/10.1097/hep.0000000000001678 Biologically explicable multimodal model predicting local tumor progression and tumor invasiveness of hepatocellular carcinoma
https://doi.org/10.3389/fnut.2025.1699958 Effects of lifestyle intervention and supplementation with insoluble oat fiber on cognitive functions in patients with prediabetes: a secondary analysis of the Optimal Fiber Trial
https://doi.org/10.3389/fendo.2025.1736543 Gastroenteropancreatic neuroendocrine neoplasms in children and adults: a comparative review
https://doi.org/10.1002/mus.880060206 Two cases of adynamia episodica hereditaria: In vitro investigation of muscle cell membrane and contraction parameters
Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinoside.